Detection of tumor cell contamination in peripheral blood by RT-PCR in gastrointestinal cancer patients.

por Noh, Y. H., Im, G., Ku, J. H., Lee, Y. S., Ahn, M. J.
Publicado 1999

Epstein Barr virus associated hemophagocytic syndrome--a case report.

por Kim, I. S., Park, C. K., Kim, H., Lee, Y. Y., Ahn, M. J., Lee, W. S.
Publicado 1997

Expression of cyclin dependent kinase inhibitor p21WAF1 alone and in combination with p27KIP1 shows prognostic value in gastric carcinoma.

por Jang, S. J., Ahn, M. J., Paik, S. S., Kong, G., Keum, J. S., Park, Y. W., Lee, J. D.
Publicado 1998

A case of leukemia cutis.

por Yu, H. J., Kim, Y. S., Yang, H. Y., Kwon, S. J., Ahn, M. J., Park, C. K.
Publicado 1998

p53 protein expression and its prognostic importance in patients with nodal non-Hodgkin's lymphoma.

por Ahn, M. J., Kim, H., Kim, I. S., Park, J. K., Ki, M. R., Park, C. K.
Publicado 2000

A complete remission can be achieved despite persistence of abnormal bone marrow promyelocytes in acute promyelocytic leukemia--experience in 2 patients.

por Kim, S. W., Lee, K. H., Lee, J. S., Suh, C., Ahn, M. J., Kim, S. W., Chi, H. S., Kim, S. H.
Publicado 1993

PP088 The case fatality rate of COVID-19 infection in non-small cell lung cancer

por Jung, Y.J., Park, S.H., Jung, H.A., Sun, J-M., Lee, S-H., Ahn, J.S., Ahn, M-J.
Publicado 2022

Eosinophilic fasciitis preceding relapse of peripheral T-cell lymphoma.

por Kim, H., Kim, M. O., Ahn, M. J., Lee, Y. Y., Jung, T. J., Choi, I. Y., Kim, I. S., Park, C. K.
Publicado 2000

A phase-1b study of everolimus plus paclitaxel in patients with small-cell lung cancer

por Sun, J M, Kim, J R, Do, I G, Lee, S Y, Lee, J, Choi, Y L, Ahn, J S, Ahn, M J, Park, K
Publicado 2013

Clinical significance of microvessel density in multiple myeloma patients.

por Ahn, M. J., Park, C. K., Choi, J. H., Lee, W. M., Lee, Y. Y., Choi, I. Y., Kim, I. S., Lee, W. S., Ki, M.
Publicado 2001

A case of prostate cancer in 34 year old man presenting with generalized lymphadenopathy mimicking malignant lymphoma.

por Ahn, M. J., Oh, S. J., Lee, Y. Y., Jung, T. J., Kim, I. S., Choi, I. Y., Jang, S. J., Park, Y. W., Shin, K. Y., Kim, Y. S.
Publicado 1997

A case of type IIa early gastric cancer developed in pernicious anemia.

por Ahn, M. J., Han, D., Park, Y. J., Park, G. T., Sohn, D. H., Lee, Y. Y., Jung, T. J., Choi, I. Y., Kim, I. S., Jang, S. J.
Publicado 1998

Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance.

por Ahn, M. J., Kim, B. H., Jang, S. J., Hong, E. K., Lee, W. M., Baik, H. K., Park, H. K., Lee, C. B., Ki, M.
Publicado 1998

Three-week schedule of irinotecan plus cisplatin in patients with previously untreated extensive-stage small-cell lung cancer

por Hong, Y S, Lee, H R, Park, S, Lee, S C, Hwang, I G, Park, B-B, Lee, J, Ahn, J S, Ahn, M-J, Lim, H Y, Park, K
Publicado 2006

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

por Jun, H J, Ahn, M J, Kim, H S, Yi, S Y, Han, J, Lee, S K, Ahn, Y C, Jeong, H-S, Son, Y-I, Baek, J-H, Park, K
Publicado 2008

A single institutional experience of thymic epithelial tumours over 11 years: clinical features and outcome and implications for future management

por Lee, H-S, Kim, S T, Lee, J, Choi, Y S, Han, J-H, Ahn, Y-C, Lee, K-S, Ahn, J S, Ahn, M J, Kim, K, Shim, Y M, Kim, J, Park, K
Publicado 2007

Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours

por Paz-Ares, L., Barlesi, F., Siena, S., Ahn, M.-J., Drilon, A., Conley, A., Rolfo, C., Wolf, J., Seto, T., Doebele, R., Kapre, A., Chen, D., McCallum, S., Osborne, S., Demetri, G.
Publicado 2021

Combination chemotherapy of oral 5'-deoxy-5-fluorouridine and cisplatin in advanced gastric cancer: a phase II study.

por Ahn, M. J., Han, D. S., Sohn, J. H., Jeon, Y. C., Jun, D. W., Choi, N. W., Park, H. K., Baik, H. K., Lee, H. G., Nam, Y. S., Choi, I. Y.
Publicado 1998

Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study

por Park, S., Sun, J.-M., Choi, Y.-L., Oh, D., Kim, H.K., Lee, T., Chi, S.A., Lee, S.-H., Choi, Y.S., Jung, S.-H., Ahn, M.-J., Ahn, Y.C., Park, K., Shim, Y.M.
Publicado 2022

Clinical impacts of tumor cell contamination of hematopoietic stem cell products in metastatic breast cancer patients undergoing autologous peripheral blood stem cell transplantati...

por Ahn, M. J., Noh, Y. H., Lee, Y. S., Lee, Y. Y., Choi, I. Y., Kim, I. S., Joh, E. K., Shin, D. B., Kim, S. Y., Cho, K. S., Kim, H. C., Kim, H. S., Suh, C. W., Kim, S. H., Lee, J. A., Park, Y. S.
Publicado 2001